Middle East And Africa Pharmacovigilance Market estimated to be growing at a CAGR of 14.36% by 2023
Middle East And Africa Pharmacovigilance Market - Industry Analysis, Size, Share, Growth, Trends, And Forecasts(2018–2023)
(EMAILWIRE.COM, November 16, 2018 ) Middle East and Africa Pharmacovigilance Market Trends:
Market Data Forecast has released a report on The Middle East and Africa Pharmacovigilance Market; Contract outsourcing holds a major share of the market revenue due to R&D initiatives for development of innovative therapeutic molecules. Phase IV are expected to grow at a high CAGR because Manufacturers are now focusing on remodeling their product development processes in an attempt to cater to patient needs across the globe
Middle East and Africa Pharmacovigilance Market Size:
Middle East and Africa Pharmacovigilance Market was worth USD 0.300 Billion in 2018 and estimated to be growing at a CAGR of 14.36%, to reach USD 0.610 Billion by 2023.
Major industry players include Boehringer Ingelheim, Accenture, Bristol-Myers Squibb, Covance, ICON, PAREXEL, Quintiles, United BioSource, Synowlwedge and Cognizant Technology Solutions Corporation.
Request for Sample @ https://www.marketdataforecast.com/market-reports/mea-pharmacovigilence-market-7811/request-sample
Recent Developments:
Bristol-Myers Squibb is a differentiated company, led by our unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. We work every day to deliver innovative medicines for patients with serious and life-threatening diseases. Each day, our employees around the world work together for patients – it drives everything we do. We are focused on helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience and fibrosis. Through our R&D organization, we have built a sustainable pipeline of potential therapies, actively partner to access external innovation to broaden and accelerate our work.
The Bristol-Myers Squibb-Pfizer Alliance presented new real-world evidence (RWE) from a sub-analysis of the ARISTOPHANES study comparing the safety and effectiveness of non-vitamin K antagonist oral anticoagulants (NOACs), including Eliquis® (apixaban), in non-valvular atrial fibrillation (NVAF) patient populations aged 80 and older (n=46,208 Eliquis increases the risk of bleeding and can cause serious, potentially fatal, bleeding.
Bristol-Myers Squibb Company and Infinity Pharmaceuticals, Inc. announced a clinical trial collaboration to evaluate Bristol-Myers Squibb's Opdivo in combination with Infinity's IPI-549 in patients with advanced urothelial cancer.
Browse Report Brief and TOC @ https://www.marketdataforecast.com/market-reports/mea-pharmacovigilence-market-7811/
Key Takeaways from this Report:
For different product types, end-use applications and industry verticals, offers calculated growth rates (CAGR %), Volume (Units), and Value ($M) in each region to estimate the market potential.
Identify various driving factors, constraints and untold opportunities that can impact the global marketplace
Know the position of your competitor based on the market shares, financial performance, strategical approaches, SWOT, product benchmarking and so on.
Increase overall revenue by understanding the geographical impact on sales and distribution channels.
Evaluate the increase in values at each step of the industry supply chain to improve process efficacy and optimize the value.
Understand the market dynamics of leading players like deals, partnerships, new products, mergers and acquisitions in the last four years.
Estimate the gaps in supply-demand, statics involved in import-export, and regulatory framework of the worldwide market in over 20 top nations.
Inquire before buying @ https://www.marketdataforecast.com/market-reports/mea-pharmacovigilence-market-7811/inquire
About Us
Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.
Market Data Forecast has released a report on The Middle East and Africa Pharmacovigilance Market; Contract outsourcing holds a major share of the market revenue due to R&D initiatives for development of innovative therapeutic molecules. Phase IV are expected to grow at a high CAGR because Manufacturers are now focusing on remodeling their product development processes in an attempt to cater to patient needs across the globe
Middle East and Africa Pharmacovigilance Market Size:
Middle East and Africa Pharmacovigilance Market was worth USD 0.300 Billion in 2018 and estimated to be growing at a CAGR of 14.36%, to reach USD 0.610 Billion by 2023.
Major industry players include Boehringer Ingelheim, Accenture, Bristol-Myers Squibb, Covance, ICON, PAREXEL, Quintiles, United BioSource, Synowlwedge and Cognizant Technology Solutions Corporation.
Request for Sample @ https://www.marketdataforecast.com/market-reports/mea-pharmacovigilence-market-7811/request-sample
Recent Developments:
Bristol-Myers Squibb is a differentiated company, led by our unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. We work every day to deliver innovative medicines for patients with serious and life-threatening diseases. Each day, our employees around the world work together for patients – it drives everything we do. We are focused on helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience and fibrosis. Through our R&D organization, we have built a sustainable pipeline of potential therapies, actively partner to access external innovation to broaden and accelerate our work.
The Bristol-Myers Squibb-Pfizer Alliance presented new real-world evidence (RWE) from a sub-analysis of the ARISTOPHANES study comparing the safety and effectiveness of non-vitamin K antagonist oral anticoagulants (NOACs), including Eliquis® (apixaban), in non-valvular atrial fibrillation (NVAF) patient populations aged 80 and older (n=46,208 Eliquis increases the risk of bleeding and can cause serious, potentially fatal, bleeding.
Bristol-Myers Squibb Company and Infinity Pharmaceuticals, Inc. announced a clinical trial collaboration to evaluate Bristol-Myers Squibb's Opdivo in combination with Infinity's IPI-549 in patients with advanced urothelial cancer.
Browse Report Brief and TOC @ https://www.marketdataforecast.com/market-reports/mea-pharmacovigilence-market-7811/
Key Takeaways from this Report:
For different product types, end-use applications and industry verticals, offers calculated growth rates (CAGR %), Volume (Units), and Value ($M) in each region to estimate the market potential.
Identify various driving factors, constraints and untold opportunities that can impact the global marketplace
Know the position of your competitor based on the market shares, financial performance, strategical approaches, SWOT, product benchmarking and so on.
Increase overall revenue by understanding the geographical impact on sales and distribution channels.
Evaluate the increase in values at each step of the industry supply chain to improve process efficacy and optimize the value.
Understand the market dynamics of leading players like deals, partnerships, new products, mergers and acquisitions in the last four years.
Estimate the gaps in supply-demand, statics involved in import-export, and regulatory framework of the worldwide market in over 20 top nations.
Inquire before buying @ https://www.marketdataforecast.com/market-reports/mea-pharmacovigilence-market-7811/inquire
About Us
Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.
Contact Information:
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek Shukla
Tel: +1-888-702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results